| Hypoxia--a key regulatory factor in tumour growth | Nature Reviews Cancer | 2002 | 4K |
| Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) | Autophagy | 2016 | 3.8K |
| Guidelines for the use and interpretation of assays for monitoring autophagy | Autophagy | 2012 | 2.8K |
| Breast cancer classification and prognosis based on gene expression profiles from a population-based study | Proceedings of the National Academy of Sciences of the United States of America | 2003 | 1.6K |
| Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis | Journal of the National Cancer Institute | 2006 | 1.5K |
| Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma | British Journal of Haematology | 2008 | 1.4K |
| Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse | Journal of Clinical Oncology | 2006 | 841 |
| ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response | Molecular Cell | 2017 | 800 |
| Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma | Molecular and Cellular Biology | 2005 | 754 |
| hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer | Clinical Cancer Research | 2008 | 555 |
| Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization | Nature Medicine | 2011 | 486 |
| Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress | Cancer Cell | 2015 | 421 |
| HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron | Cancer Cell | 2002 | 410 |
| Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours | European Journal of Cancer | 2002 | 397 |
| The type 1 insulin-like growth factor receptor pathway | Clinical Cancer Research | 2008 | 342 |
| Advances in Hypoxia-Inducible Factor Biology | Cell Metabolism | 2018 | 330 |
| New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomes | Blood | 2010 | 305 |
| Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function | Cancer Research | 2005 | 288 |
| Tumor-associated macrophages in breast cancer | Journal of Mammary Gland Biology and Neoplasia | 2002 | 286 |
| Consensus guidelines for the use and interpretation of angiogenesis assays | Angiogenesis | 2018 | 285 |
| Regulation of autophagy by ATF4 in response to severe hypoxia | Oncogene | 2010 | 266 |
| Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo | Cancer Research | 2007 | 265 |
| Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers | Cancer Research | 2007 | 257 |
| microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer | Cancer Research | 2011 | 253 |
| Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells | Cancer Research | 2003 | 252 |
